SA

Stephen Anastasiou

Mr Anastasiou has over 20 years of experience in general management, marketing and strategic planning within the healthcare industry. His experience incorporates medical diagnostics, pharmaceuticals, hospital, dental and over-the-counter products, with companies including the international pharmaceutical company Bristol-Myers Squibb (NYSE: BMY). Mr. Anastasiou is also a director and shareholder of a number of unlisted private companies, covering a variety of industry sectors, that have participated in Corporate transaction with both local and International Companies

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/23N/A4,882,3881,800,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
13/06/22
Transfer
468,750$0.100$46,875Off-market transfer
13/06/22
Transfer
468,750$0.100$46,875Off-market transfer
13/06/22
Expiry
1,308,280$0.100$130,828Options expired
13/11/20
Issued
1,800,000$0.255$459,000Issue of securities
13/11/20
Issued
468,750$0.080$37,500Issue of securities